Vizsgálati helyszín
Holy Name Medical Center
Teaneck, New Jersey 07666, Egyesült ÁllamokMég nincs intézményhez kötve
- 16futó vizsgálat
- 12lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 28 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis10 vizsgálat
- 2. fázis5 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz9 vizsgálat
- Lezárult9 vizsgálat
- Toboroz7 vizsgálat
- Leállították3 vizsgálat
- Fő szponzor
- Genmab2 vizsgálat
- Janssen Research & Development, LLC2 vizsgálat
- Abbott Medical Devices1 vizsgálat
- AbbVie1 vizsgálat
- Adaptive Phage Therapeutics, Inc.1 vizsgálat
- és még 21
Futó vizsgálatok
Toboroz
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
NCT07166094· 3. fázis· Genmab· Forrás
Toboroz
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
NCT07213778· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
NCT06846281· 3. fázis· Novartis Pharmaceuticals· Forrás
Contact: Diome Kramer
Fut, nem toboroz
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236· 3. fázis· Genmab· Forrás
Fut, nem toboroz
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06564311· 2. fázis· Zenas BioPharma (USA), LLC· Forrás
Toboroz
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT05659381· 3. fázis· GOG Foundation· Forrás
Contact: Marissa Van Orden
Toboroz
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418· Cleerly, Inc.· Forrás
Contact: Jaffar Raza, MD
Fut, nem toboroz
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
NCT05907564· Inquis Medical, Inc.· Forrás
Fut, nem toboroz
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
SELUTION4SFA Trial
NCT05132361· M.A. Med Alliance S.A.· Forrás
Fut, nem toboroz
MOTIV BTK Randomized Controlled Trial
NCT05406622· REVA Medical, Inc.· Forrás
Toboroz
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
NCT04613596· 2/3. fázis· Mirati Therapeutics Inc.· Forrás
Contact: Yadyra Rivera, Site 007-784
Fut, nem toboroz
Abemaciclib and Letrozole to Treat Endometrial Cancer
NCT04393285· 2. fázis· Gynecologic Oncology Group· Forrás
Fut, nem toboroz
LIFE-BTK Randomized Controlled Trial
NCT04227899· Abbott Medical Devices· Forrás
Fut, nem toboroz
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
NCT04232553· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927· Stryker Instruments· Forrás
Contact: Angie Lee
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Toboroz
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT06667076· 2. fázis· Janssen Research & Development, LLC· Forrás
Leállították
Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice
NCT05978531· Banner Life Sciences LLC· Forrás
Toboroz
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917· Inari Medical· Forrás
Contact: Mark Sung
Toboroz
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NCT05313165· LimFlow, Inc.· Forrás
Contact: Erin Towery
Lezárult
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
NCT05358353· ReFlow Medical, Inc.· Forrás
Leállították
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107· 2. fázis· Adaptive Phage Therapeutics, Inc.· Forrás
Lezárult
Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
NCT04580160· Vesper Medical, Inc.· Forrás
Lezárult
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
NCT04374630· 2. fázis· Laekna Limited· Forrás
Lezárult
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression
NCT04209855· 3. fázis· AbbVie· Forrás
Lezárult
The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
NCT03551496· 3. fázis· Boston Scientific Corporation· Forrás
Lezárult
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
NCT03517449· 3. fázis· Eisai Inc.· Forrás
Lezárult
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
NCT03241459· SurModics, Inc.· Forrás
Hibát jelzek